Soleus Capital Management’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
Soleus Capital Management's RXST Position: Q3 2026 in Review
Soleus Capital Management opened a new position in RxSight (RXST) in Q3 2026: 20,000 shares worth $98K. The stake represents ﹤0.01% of the portfolio and ranks #96 among its holdings. This is a return to the name: Soleus Capital Management previously reported a position in RXST as recently as Q1 2023.
Soleus Capital Management first reported a position in RXST in Q1 2023 and has held it in 2 quarters since. The position peaked at $1.33M in Q1 2023. 156 funds tracked by Wall St. Rank hold RXST as of Q3 2026.
- Soleus Capital Management held 20,000 shares of RxSight worth $98K as of Q3 2026.
- RxSight was a new Soleus Capital Management position in Q3 2026.
- RxSight made up ﹤0.01% of Soleus Capital Management's portfolio in Q3 2026, its #96 holding.
- Soleus Capital Management first reported a position in RxSight in Q1 2023 and has held it in 2 quarters since.
- Soleus Capital Management's RxSight position peaked at $1.33M in Q1 2023.
- 156 funds tracked by Wall St. Rank held RxSight as of Q3 2026.
Based on Soleus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.